Cargando…
RET fusion mutation detected by re-biopsy 7 years after initial cytotoxic chemotherapy: A case report
Personalized medicine using molecular-targeted drugs to achieve better therapeutic response and long-term prognosis is common practice for lung cancer treatment. However, in cases before gene batch tests were available, medical treatment continued without the detection of rare mutations. We report a...
Autores principales: | Morikawa, Kei, Handa, Hiroshi, Ueno, Junko, Tsuruoka, Hajime, Inoue, Takeo, Shimada, Naoki, Koike, Junki, Nakamura, Seiji, Sato, Yoshiharu, Mineshita, Masamichi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9702555/ https://www.ncbi.nlm.nih.gov/pubmed/36452495 http://dx.doi.org/10.3389/fonc.2022.1019932 |
Ejemplares similares
-
Efficacy of combined transbronchial lung cryobiopsy and conventional forceps biopsy for lung malignancies: a prospective cohort study
por: Kinoshita, Kohei, et al.
Publicado: (2023) -
Differences in skeletal muscle loss caused by cytotoxic chemotherapy and molecular targeted therapy in patients with advanced non‐small cell lung cancer
por: Kakinuma, Kazutaka, et al.
Publicado: (2017) -
A Prospective Validation Study of Lung Cancer Gene Panel Testing Using Cytological Specimens
por: Morikawa, Kei, et al.
Publicado: (2022) -
Pre-treatment bronchoscopic evaluation in a case of relapsing polychondrits
por: Kumagai, Kosumi, et al.
Publicado: (2023) -
Detection of a pinhole‐sized bronchoesophageal fistula under bronchoscopic autofluorescence imaging
por: Morikawa, Kei, et al.
Publicado: (2021)